Vasoactive intestinal peptide (VIP) is an abundant neurotransmitter in the lungs and other
organs. Its discovery dates back to 1970. And VIP gains attention again due to the potential …

Abstract Purpose of review: Vasoactive Intestinal Peptide (VIP) is a neuropeptide, expressed
by lymphoid as well as neural cells, which has diverse effects on the cellular mediators of …

There is mounting evidence that pulmonary arterial hypertension (PAH), asthma and chronic
obstructive pulmonary disease (COPD) share important pathological features, including …

Chronic inflammatory airway diseases such as bronchial asthma or chronic obstructive
pulmonary disease (COPD) are major contributors to the global burden of disease. Although …

Rationale Stable analogs of vasoactive intestinal peptide (VIP) have been proposed as
novel line of therapy in chronic obstructive pulmonary disease (COPD) based on their …

VIP was first isolated from the small intestine, but it had been discovered earlier in the lung,
as a vasodilator peptide [1, 2]. Several years later it was identified in the central and …

Vasoactive intestinal peptide (VIP) is one of the most abundant molecules found in the
respiratory tract. Due to its anti-inflammatory and bronchodilatatory properties, it has been …

Vasoactive intestinal polypeptide (VIP) is one of the most abundant, biologically active
peptides found in the human lung. VIP is a likely neurotransmitter or neuromodulator of the …

As a neuropeptide with wide distribution, vasoactive intestinal polypeptide (VIP) is a likely
neurotransmitter or neuromodulator. Though first isolated from small intestine, VIP had …

Vasoactive intestinal peptide (VIP) is a potent vasorelaxing peptide that plays a role in lung
physiology and possibly in pulmonary hypertension. We investigated the turnover of the VIP …